"We Envision Growth Strategies Most Suited
to Your Business"

Pharmacovigilance Market to Register Remarkable CAGR of 13.1% between 2021 and 2028; Uppsala Monitoring Centre Launches Novel Drug Safety Solution for Geriatric Population to Spur Development Prospects

December 17, 2021 | Healthcare

The global pharmacovigilance market size was USD 5.56 billion in 2020. The market is projected to grow from USD 6.28 billion in 2021 to USD 14.85 billion in 2028 at a CAGR of 13.1% in the 2021-2028 period.


This information is provided by Fortune Business Insights™, in its report, titled, “Pharmacovigilance (PV) Market Size, Share & COVID-19 Impact Analysis, By Type (Service and Software), By Deployment (In-house and Outsource), By End-User (Hospitals, Pharmaceutical Companies, and Others), and Regional Forecast, 2021-2028.”


The main objective of the PV industry is to enhance patient care and safety concerning the use of medicines. It also supports public health programs by providing reliable and balanced information for the correct assessment of the adverse effects of medicines.


R&D for Nobel Vaccines to Boost the PV Market


PV outsourcing is attaining impulse in revenue and development due to progressions in the PV software and services. The presence of an information technology platform has paved a positive path for the global market.


Moreover, the incidence of COVID-19 has opened frequent prospects for pharmaceutical companies to invent novel vaccines, which have activated several clinical judgments. This factor has even paved the way for the PV market as it is the most prominent phase of any drug development course.


To get a detailed report summary and research scope of this market, click here:


https://www.fortunebusinessinsights.com/pharmacovigilance-pv-market-102746


PrimeVigilance Extends Business Functions in Japan


Ergomed plc, which is a company fixated on offering dedicated facilities to the pharmaceutical industry, declares that its PrimeVigilance business, who is a global frontrunner in the provision of pharmacovigilance and medical information services, has recognized its novel legal unit and regional workplace in Japan and is completely functioning from 26 April 2021.


This development offers prevailing and potential international PrimeVigilance clienteles the prospect to encompass their product coverage into the tactically significant Japanese pharmaceutical market, which is the fourth biggest across the globe after the U.S., the EU, and China.


Subcontracting of PV Services to Accelerate Market Growth


This market permits an option for pharmaceutical companies and clinics to subcontract the PV service. PV outsourcing has the majority benefits to the manufacturing companies in terms of time constrictions and amenities that an outsourced service can deliver. Outsourcing also sanctions the companies to endure modification according to their demands and desires, which can augment the pace of the assessment procedure. This factor is expected to boost the pharmacovigilance market growth.


Approval of Multifold Tactics by Key Players to Advance PV Business to Drive Competition


The market is home to numerous players. Vendors such as Solutions, Accenture plc, Cognizant Technology, IQVIA, and several others have effectively proven their position through numerous achievements, progressive pharmacovigilance solutions, and outstanding customer-provider relationships. These companies are fixated on delivering end-to-end solutions to customers by extemporizing continuous tactical expansions and offering specialized PV services.


Industry Development



  • January 2020: Uppsala Monitoring Centre unveiled an attentiveness movement on polypharmacy and security usage of medications among the geriatric population.


List of Key Players Covered in the PV Market Report



  • Covance Inc. (U.S.)

  • Parexel International Corporation  (U.S.)

  • Accenture plc (Ireland)

  • Cognizant (U.S.)

  • Bioclinica (U.S.)

  • Pharmaceutical Product Development, LLC (U.S.)

  • ICON plc (Ireland)

  • Quanticate (U.S.)


Further Findings



  • The services segment held a dominant position in 2020, generating the highest and having the largest market share.

  • The market size in North America was worth USD 2.23 billion in 2020, denoting its top position. North America holds the highest pharmacovigilance market share, owing to the region's largest number of PV happenings.


Table of Segmentation






















































  ATTRIBUTE



  DETAILS



Study Period



2017-2028



Base Year



2020



Estimated Year



 2021



Forecast Period



2021-2028



Historical Period



2017-2019



Unit



Value (USD billion)



Segmentation



Type, Deployment, End-User, and Geography



By Type


 




  • Service

  • Software



By Deployment


 




  • In-house

  • Outsource



By End-User


 




  • Hospitals

  • Pharmaceutical Companies

  • Others



By Geography


 




  • North America (By Type, By Deployment, By End-User, and by Country)

    • U.S. (By Type)

    • Canada (By Type)



  • Europe (By Type, By Deployment, By End-User, and by Country)

    • U.K. (By Type)

    • Germany (By Type)

    • France (By Type)

    • Italy (By Type)

    • Spain (By Type)

    • Rest of Europe (By Type)



  • Asia Pacific (By Type, By Deployment, By End-User, and by Country)

    • China (By Type)

    • Japan (By Type)

    • India (By Type)

    • Australia (By Type)

    • Southeast Asia (By Type)

    • Rest of Asia Pacific (By Type)



  • Latin America (By Type, By Deployment, By End-User, and by Country)

    • Brazil (By Type)

    • Mexico (By Type)

    • Rest of Latin America (By Type)



  • Middle East & Africa (By Type, By Deployment, By End-User, and by Country)

    • GCC (By Type)

    • South Africa (By Type)

    • Rest of Middle East & Africa (By Type)




Pharmacovigilance (PV) Market
  • PDF
  • 2020
  • 2017-2019
  • 113

    CHOOSE LICENSE TYPE

  • 4850
    5850
    7850

Our Clients

SPG
Lek
Ipsos
Radico
Oecc
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X